Deutsche Bank Starts Fluidigm Corporation (FLDM) at Buy; Nano Tech But Big Help to Lab

Deutsche Bank initiates coverage on Fluidigm Corporation (NASDAQ: FLDM) with a Buy. PT $19.

Deutsche analyst says, "FLDM is a leading microfluidics company that provides genomic analysis tools for government /academic, biopharma and AgBio end markets. FLDM's technology has several advantages over traditional techniques, including higher throughput, high data quality and low reagent usage. The company has an exhaustive IP portfolio, and its technology has been validated in peer reviewed journals, providing it a commercial lead over the competition. Given its leverage to high growth markets, we are initiating coverage of FLDM with a Buy."

For more ratings news on Fluidigm Corporation click here and for the rating history of Fluidigm Corporation click here.

Shares of Fluidigm Corporation closed at $15.13 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
• Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
• Piper Sandler Starts Dave Inc (DAVE) at Overweight